All > Seborrheic Dermatitis > Atopic Dermatitis

Active for Atopic Dermatitis

Phase-Based Progress Estimates
1
Effectiveness
2
Safety
Northwest AR Clinical Trials Center, PLLC, Rogers, ARAtopic DermatitisEVO101 - Drug
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will test a new drug to treat atopic dermatitis in adults to see if it's safe & effective.

Eligible Conditions
  • Atopic Dermatitis

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
Plaque Psoriasis PF-07038124 0.06% ointment
1
ADX-914
1
Afamelanotide

Study Objectives

1 Primary · 3 Secondary · Reporting Duration: 8 weeks

8 weeks
Body Surface Area (BSA)
Eczema Area and Severity Index (EASI)
Investigator Global Assessment (IGA)
Pruritus-NRS

Trial Safety

Safety Progress

2 of 3
This is further along than 68% of similar trials

Similar Trials

2
Plaque Psoriasis PF-07038124 0.06% ointment
2
ADX-914
2
Afamelanotide

Trial Design

4 Treatment Groups

Active
1 of 4
EVO101 Cream
1 of 4
Vehicle
1 of 4
Vehicle Cream
1 of 4

Experimental Treatment

Non-Treatment Group

118 Total Participants · 4 Treatment Groups

Primary Treatment: Active · Has Placebo Group · Phase 2

Active
Drug
Experimental Group · 1 Intervention: EVO101 · Intervention Types: Drug
EVO101 Cream
Drug
Experimental Group · 1 Intervention: EVO101 · Intervention Types: Drug
Vehicle
Drug
PlaceboComparator Group · 1 Intervention: EVO101 · Intervention Types: Drug
Vehicle Cream
Drug
PlaceboComparator Group · 1 Intervention: EVO101 · Intervention Types: Drug

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 8 weeks

Who is running the clinical trial?

Evommune, Inc.Lead Sponsor
Eugene Bauer, MDStudy DirectorEvommune, Inc.
3 Previous Clinical Trials
488 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 5 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have been experiencing eczema for over a year.
References

Frequently Asked Questions

Do numerous hospitals in Canada support this research?

"Dermatology Research Associates, Centre for Clinical Studies, Ltd LLC, and Minnesota Clinical Study Centre are the lead institutions running this trial, with support from 15 other locations." - Anonymous Online Contributor

Unverified Answer

Are there any possible side effects to using EVO101 Cream?

"Since this is a Phase 2 trial, EVO101 Cream received a score of 2. This is because while there is some data supporting the cream's safety, there is no data supporting its efficacy." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top